Worldwide transmission of drug-resistant HIV.

作者: Annemarie M Wensing , Charles A Boucher

DOI:

关键词: Antiretroviral therapyPublic healthTransmission (medicine)Intensive care medicineHuman immunodeficiency virus (HIV)MedicineChronic conditionIncidence (epidemiology)ImmunologyVirusDrug resistance

摘要: The availability of highly active antiretroviral therapy (HAART), that suppresses replication the human immunodeficiency virus type 1 (HIV-1), has dramatically improved prognosis HIV-infected patients. In populations with access to HAART, course infection changed from an inevitably fatal disease, characterized by a high incidence opportunistic infections, into potentially-treatable chronic condition. Unfortunately, HAART does not durably suppress HIV in 20-50% treatment-naive patients and up 50-70% treatment-experienced majority viral rebound, drug-resistance-related mutations are detected. New infections through transmission drug-resistant strains individuals who have never been exposed now being increasingly reported, despite all prevention efforts. Moreover, recent reports correlate new suboptimal response, which raises major public health concerns. Despite large number publications on rate primary resistance, it is very difficult draw general conclusions. variation methodology interpretation illustrates need for systematic approaches. Global surveillance urgently warranted monitor circulating HIV-strains. addition, follow-up research be performed reveal impact drug resistance future options. This paper reviews current literature elucidate mechanisms, implications magnitude HIV-1.

参考文章(82)
N. K. Back, M. Nijhuis, W. Keulen, C. A. Boucher, B. O. Oude Essink, A. B. van Kuilenburg, A. H. van Gennip, B. Berkhout, Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. The EMBO Journal. ,vol. 15, pp. 4040- 4049 ,(1996) , 10.1002/J.1460-2075.1996.TB00777.X
Bluma Brenner, Mark A Wainberg, Horacio Salomon, Danielle Rouleau, André Dascal, Bonnie Spira, Rafik-Pierre Sekaly, Brian Conway, Jean-Pierre Routy, Resistance to antiretroviral drugs in patients with primary HIV-1 infection International Journal of Antimicrobial Agents. ,vol. 16, pp. 429- 434 ,(2000) , 10.1016/S0924-8579(00)00270-3
Helen L. Devereux, Mike Youle, Margaret A. Johnson, Clive Loveday, Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy AIDS. ,vol. 13, pp. 123- 127 ,(1999) , 10.1097/00002030-199912240-00001
Thomas d'Aquin Toni, Bernard Masquelier, Dominique Bonard, Muriel Faure, Charlotte Huët, Anne Caumont, Pierre Roques, François Dabis, Roger Salamon, Hervé Fleury, Primary HIV-1 drug resistance in Abidjan (Côte d'Ivoire): a genotypic and phenotypic study. AIDS. ,vol. 16, pp. 488- 491 ,(2002) , 10.1097/00002030-200202150-00024
Teresa Puig, Mayte Pérez-Olmeda, Amalia Rubio, Lidia Ruiz, Carlos Briones, José M Franco, María Gómez-Cano, Lieven Stuyver, Laura Zamora, Camilo Alvarez, Manolo Leal, Bonaventura Clotet, Vicente Soriano, ERASE-2 Study Group, None, Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. AIDS. ,vol. 14, pp. 727- 732 ,(2000) , 10.1097/00002030-200004140-00012
Scott A. Wegner, Stephanie K. Brodine, John R. Mascola, Sybil A. Tasker, Richard A. Shaffer, Monica J. Starkey, Anthony Barile, Gregory J. Martin, Naomi Aronson, Wesley W. Emmons, Kevin Stephan, Stuart Bloor, Johan Vingerhoets, Kurt Hertogs, Brendan Larder, Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel. AIDS. ,vol. 14, pp. 1009- 1015 ,(2000) , 10.1097/00002030-200005260-00013
Christopher D Pilcher, Joseph J Eron Jr, Pietro L Vemazza, Manuel Battegay, Thomas Harr, Sabine Yerly, Samir Vom, Luc Perrin, Sexual Transmission During the Incubation Period of Primary HIV Infection JAMA: The Journal of the American Medical Association. ,vol. 286, pp. 1713- 1714 ,(2001) , 10.1001/JAMA.286.14.1713
Milton C. Weinstein, Sue J. Goldie, Elena Losina, Calvin J. Cohen, John D. Baxter, Hong Zhang, April D. Kimmel, Kenneth A. Freedberg, Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness Annals of Internal Medicine. ,vol. 134, pp. 440- 450 ,(2001) , 10.7326/0003-4819-134-6-200103200-00008
Horacio Salomon, Mark A Wainberg, Bluma Brenner, Yudong Quan, Danielle Rouleau, Pierre Coté, Roger LeBlanc, Eric Lefebvre, Bonnie Spira, Chris Tsoukas, Rafik-Pierre Sekaly, Brian Conway, Douglas Mayers, Jean-Pierre Routy, Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. AIDS. ,vol. 14, ,(2000) , 10.1097/00002030-200001280-00003
Laura Romano, Giulietta Venturi, Rebecca Ferruzzi, Maria Letizia Riccio, Paola Corsi, Francesco Leoncini, Assunta Vinattieri, Laura Incandela, Pier E. Valensin, Maurizio Zazzi, Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. AIDS. ,vol. 14, pp. 2204- 2206 ,(2000) , 10.1097/00002030-200009290-00019